Tissue Regenix Group announced that Chief Financial Officer (CFO), Mike Barker, has resigned from his position for personal reasons and will leave the Company at the end of November. Group Financial Controller, Kirsten Lund, has been appointed Group Finance Director and will resume these responsibilities with immediate effect allowing for an orderly handover. Kirsten Lund is not being appointed to the Board of the Company at the current time.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71.5 GBX | +2.14% |
|
+8.33% | +37.50% |
Jun. 14 | Tissue Regenix purchases Texas facility to generate cost savings | AN |
Jun. 14 | Tissue Regenix Buys Leased Property in Texas | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+37.50% | 66.16M | |
-2.39% | 30.38B | |
+37.51% | 9.35B | |
+35.03% | 4.45B | |
-40.39% | 2.26B | |
-6.10% | 1.66B | |
-29.44% | 1.22B | |
-41.27% | 1.01B | |
-6.21% | 840M | |
-49.31% | 707M |
- Stock Market
- Equities
- TRX Stock
- News Tissue Regenix Group plc
- Tissue Regenix Group Announces Resignation of Mike Barker Chief Financial Officer